Kevin Young, EVP, Commercial Operations at GILEAD SCIENCES INC (GILD), sold 30,000 shares at $51.95 ($1.6M) on 2008-07-08, disclosed to the SEC on 2008-07-10.
Scheduled sale ($1.6M) by EVP, Commercial Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.70 | 2,000 | $103K | 6.7% |
| 2 | $51.75 | 2,500 | $129K | 8.3% |
| 3 | $51.77 | 200 | $10K | 0.7% |
| 4 | $51.78 | 11,800 | $611K | 39.3% |
| 5 | $51.80 | 3,000 | $155K | 10.0% |
| 6 | $51.80 | 8,760 |
| $454K |
| 29.2% |
| 7 | $51.95 | 200 | $10K | 0.7% |
| 8 | $52.00 | 1,540 | $80K | 5.2% |
| Total | $51.79 avg | 30,000 | $1.6M | 100% |
| Filing → |
| GILD | SELL | 2013-12-24 | $5.6M | — | Filing → |
| GILD | SELL | 2013-11-25 | $5.6M | — | Filing → |
| GILD | SELL | 2013-10-25 | $5.1M | — | Filing → |